艾昆纬(IQV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IQV 艾昆纬

盘前交易 09-29 05:38:11 EDT

270.97

+0.60

+0.22%

盘前273.00

+2.03+0.75%

05:01 EDT

最高272.75	最低265.97	成交量162.09万
今开266.52	昨收270.37	日振幅2.51%
总市值446.02亿	流通市值409.16亿	总股本1.65亿
成交额4.39亿	换手率1.07%	流通股本1.51亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IQV","market":"US","secType":"STK","nameCN":"艾昆纬","latestPrice":270.97,"timestamp":1790625600000,"preClose":270.37,"halted":0,"volume":1620938,"hourTrading":{"tag":"盘前","latestPrice":273,"preClose":270.97,"latestTime":"05:01 EDT","volume":366,"amount":99912.31602,"timestamp":1790672462758,"change":2.03,"changeRate":0.007492,"amplitude":0.00262},"delay":0,"changeRate":0.002219181122166005,"floatShares":151000000,"shares":164600000,"eps":8.072599,"marketStatus":"盘前交易","change":0.6,"latestTime":"09-29 05:38:11 EDT","open":266.52,"high":272.75,"low":265.9722,"amount":438950885.70652,"amplitude":0.025069,"askPrice":296.88,"askSize":100,"bidPrice":239.75,"bidSize":100,"shortable":3,"etf":0,"ttmEps":8.072599,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1790688600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1368072000000,"exchange":"NYSE","adjPreClose":270.97,"preHourTrading":{"tag":"盘前","latestPrice":273,"preClose":270.97,"latestTime":"05:01 EDT","volume":366,"amount":99912.31602,"timestamp":1790672462758,"change":2.03,"changeRate":0.007492,"amplitude":0.00262},"postHourTrading":{"tag":"盘后","latestPrice":270.97,"preClose":270.97,"latestTime":"19:43 EDT","volume":46004,"amount":12465701.3607,"timestamp":1790639030325,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.1588725632094132,"impliedVol":0.4043,"impliedVolPercentile":0.568},"requestUrl":"/m/hq/s/IQV","defaultTab":"news","newsList":[{"id":"2666253826","title":"艾昆纬拟发行20亿美元2034年到期高级债券。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666253826","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666253826?lang=zh_cn&edition=full","pubTime":"2026-09-09 20:17","pubTimestamp":1788956222,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0648000940.SGD","BK4585","LU0130517989.USD","HEAL","LU0477156953.USD","LU1989764748.USD","LU1791710582.SGD","LU0130102774.USD","LU0648001328.SGD","LU0882574055.USD","LU0980610538.SGD","LU1791710400.SGD","EKG","BNDW","LU1989764664.SGD","BK4530","IQV","LU1201861165.SGD","BK4588","LU0130518102.USD","LU1261432733.SGD","LU1201861249.SGD","LU0477156797.USD","BK4121","LU0198837287.USD","LU0528227936.USD","LU0130103400.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176319981","title":"异动解读｜艾昆纬夜盘上涨5.03%，RBC上调目标价至247美元看好利润率扩张前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1176319981","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176319981?lang=zh_cn&edition=full","pubTime":"2026-07-30 14:54","pubTimestamp":1785394491,"startTime":"0","endTime":"0","summary":"7月30日，艾昆纬夜盘上涨5.03%，报260.0美元/股，成交额7.52万美元。消息面上，RBC Capital Markets于7月29日发布研报，将艾昆纬目标价从221美元上调至247美元，维持\"跑赢大市\"评级，认为公司在运营效率提升、商业解决方案板块利润率增厚及经营杠杆释放等多重因素推动下，具备向2027年持续扩张利润率的有利条件。RBC指出，公司技术差异化优势正在夺取市场份额，CRO活动拐点将持续加速。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"艾昆纬夜盘上涨5.03%，RBC上调目标价至247美元看好利润率扩张前景","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108676759","title":"异动解读 | Q2业绩全面超预期并上调全年指引，艾昆纬盘中大涨12.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=1108676759","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1108676759?lang=zh_cn&edition=full","pubTime":"2026-07-28 21:45","pubTimestamp":1785246340,"startTime":"0","endTime":"0","summary":"艾昆纬今日盘中股价大幅上涨12.92%，引发市场广泛关注。消息面上，公司于今日盘前发布了2026年第二季度财报，业绩全面超出市场预期。数据显示，艾昆纬第二季度营收达到43.7亿美元，同比增长8.7%，高于分析师预期的43.0亿美元；调整后每股收益为3.15美元，同比增长12.1%，远超市场预期的3.03美元。此前7月份已有多家华尔街投行密集上调艾昆纬目标价，市场对公司增长前景持续看好。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134414099","title":"异动解读｜艾昆纬盘中上涨10.21%，Q2业绩全面超预期并上调全年指引","url":"https://stock-news.laohu8.com/highlight/detail?id=1134414099","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1134414099?lang=zh_cn&edition=full","pubTime":"2026-07-28 21:30","pubTimestamp":1785245434,"startTime":"0","endTime":"0","summary":"7月28日，艾昆纬盘中上涨10.21%，报234.8美元/股，成交额1366.82万美元。消息面上，公司发布第二季度财报，业绩全面超出市场预期并上调全年业绩指引。具体数据显示，Q2调整后每股收益为3.15美元，超出市场预期的3.03美元，同比增长12.1%；营收43.7亿美元，超出预期的43.0亿美元。公司同步上调全年指引，预计调整后EPS为12.80至13.00美元，全年营收上调至172.8亿至174.8亿美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145936974","title":"异动解读 | 艾昆纬盘前大涨近6%，Q2财报发布在即叠加多家投行密集上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1145936974","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145936974?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:04","pubTimestamp":1785236652,"startTime":"0","endTime":"0","summary":"艾昆纬今日盘前股价大幅上涨5.99%，引发市场广泛关注。消息面上，今日为公司第二季度财报的发布日，市场普遍预期其每股收益将达到2.72美元。在此之前，多家华尔街投行于7月份密集上调了艾昆纬的目标价：Baird将其目标价上调至252美元、Mizuho上调至230美元、汇丰上调至240美元、Evercore ISI则上调至225美元，且均维持“买入”或“跑赢大市”的评级。回顾上一季度业绩，艾昆纬每股收益为2.90美元，超出市场预期，营收同样超出预期。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180529321","title":"异动解读｜艾昆纬盘前上涨5.53%，Q2财报发布叠加多家投行上调目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=1180529321","media":"行情直击","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1180529321?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:03","pubTimestamp":1785236618,"startTime":"0","endTime":"0","summary":"7月28日，艾昆纬盘前上涨5.53%，报226.33美元/股，成交额26.52万美元。消息面上，7月以来多家投行密集上调艾昆纬目标价：Baird上调至252美元、Mizuho上调至230美元、HSBC上调至240美元、Evercore ISI上调至225美元，均维持买入或跑赢大市评级。此前Q1公司EPS为2.90美元，超预期2.84%，营收41.51亿美元同样超出市场估计，RBC指出有机增长加速及AI顺风为正面信号。公司全年营收指引维持171.5亿至173.5亿美元，管理层强调专利到期潮及AI驱动创新需求将持续提升CRO服务需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读｜艾昆纬盘前上涨5.53%，Q2财报发布叠加多家投行上调目标价","news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168878595","title":"异动解读｜艾昆纬盘中上涨8.48%，多家投行密集上调目标价叠加二季报临近","url":"https://stock-news.laohu8.com/highlight/detail?id=1168878595","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168878595?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:31","pubTimestamp":1784813500,"startTime":"0","endTime":"0","summary":"7月23日，艾昆纬盘中上涨8.48%，报215.1美元/股，成交额185.6万美元。消息面上，近期多家投行密集上调艾昆纬目标价：Baird将目标价上调至252美元，HSBC和Leerink Partners均上调至240美元，Mizuho上调至230美元，Evercore ISI上调至225美元，均维持看好评级。公司将于7月28日盘前发布二季报，市场预期调整后EPS为2.72美元，提前布局情绪显著升温。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116395216","title":"异动解读｜艾昆纬盘前上涨5.78%，多家机构密集上调目标价叠加财报临近","url":"https://stock-news.laohu8.com/highlight/detail?id=1116395216","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116395216?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:10","pubTimestamp":1784812245,"startTime":"0","endTime":"0","summary":"7月23日，艾昆纬盘前上涨5.78%，报210.0美元/股，成交额66.42万美元。消息面上，近期多家投行密集上调艾昆纬目标价：Leerink Partners将目标价从213美元上调至240美元，Baird上调至252美元，Mizuho上调至230美元，均维持跑赢大盘评级。此外，公司将于7月28日盘前发布二季报，市场提前布局情绪升温。管理层此前指引全年营收171.5亿至173.5亿美元，AI赋能及临床试验复苏构成中期增长逻辑。同日生命科学工具和服务板块整体走强，赛默飞世尔涨5.99%，形成板块共振。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104153734","title":"异动解读｜艾昆纬盘中上涨6.11%，Baird上调目标价至249美元提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1104153734","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104153734?lang=zh_cn&edition=full","pubTime":"2026-07-02 00:05","pubTimestamp":1782921927,"startTime":"0","endTime":"0","summary":"7月2日，艾昆纬盘中上涨6.11%，报205.02美元/股，成交额1.6亿美元。消息面上，Baird于7月1日将艾昆纬目标价从230美元上调至249美元，维持\"跑赢大盘\"评级，较当前股价仍有约21%的上行空间。FactSet统计显示，分析师对该股的一致评级为\"买入\"，平均目标价224.17美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143206979","title":"一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143206979","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1143206979?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:18","pubTimestamp":1782699520,"startTime":"0","endTime":"0","summary":"默克提出每股73美元的收购要约后，Bio-Techne股价本周上涨22.5%，较该公司周三收盘价溢价24%。艾伯维斥资109亿美元收购Apogee，强化免疫学领域战略艾伯维股价本周上涨17%。联合大陆航空股价上涨，油价下跌和分析师看涨情绪提振航空股本周，联合大陆航空股价上涨15%。为了进一步提升股东价值，康宁董事会宣布派发每股0.28美元的季度股息。股息将于9月29日支付给截至8月31日登记在册的股东。","market":"us","thumbnail":"https://static.tigerbbs.com/98882962e3042a24d8295da8457c9db5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/98882962e3042a24d8295da8457c9db5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["INCY","TECH","CRL","IQV","GLWG","RVTY","ABBV","UAL","GLW"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1101405459","title":"艾昆纬与科兴生物制药深化战略协作，借助AI赋能加速全球生物类似药开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1101405459","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101405459?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:33","pubTimestamp":1778704391,"startTime":"0","endTime":"0","summary":"艾昆纬与科兴生物制药宣布扩大战略合作，旨在利用人工智能赋能的技术能力，加速全球范围内生物类似药的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156797.USD","IQV","LU0130102774.USD","LU0198837287.USD","LU0648000940.SGD","LU0980610538.SGD","LU0130518102.USD","LU1261432733.SGD","LU1989764748.USD","BK4585","LU1201861249.SGD","BK4121","LU0882574055.USD","LU0130103400.USD","LU0477156953.USD","BK4530","LU1201861165.SGD","LU0130517989.USD","LU1791710400.SGD","LU1791710582.SGD","LU0528227936.USD","LU1989764664.SGD","LU0648001328.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105509238","title":"礼来减肥药Foundayo美国处方量持续攀升 5月首周达7335份","url":"https://stock-news.laohu8.com/highlight/detail?id=1105509238","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105509238?lang=zh_cn&edition=full","pubTime":"2026-05-08 19:06","pubTimestamp":1778238363,"startTime":"0","endTime":"0","summary":"根据分析师分享的艾昆纬最新数据，在截至5月1日的一周内，礼来公司减肥药物Foundayo在美国市场的处方量达到7335份。这一数字显示出该药物在医疗减肥领域的市场渗透力正在稳步提升。Foundayo作为礼来产品组合中的重要成员，其处方趋势直接反映了公司在该细分市场的战略布局成效。当前美国减肥药物市场年规模已突破百亿美元，且保持双位数增长率，这使得各家药企的市占率变化备受资本市场关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225283273.USD","LU0823416689.USD","LU1093756325.SGD","LU0683600562.USD","LU0689472784.USD","LU2168564149.EUR","LU2211815571.USD","SG9999015952.SGD","LU2237438978.USD","LU2746668461.USD","LU0133085943.USD","LU2471134952.CNY","LU0640476718.USD","LU0096364046.USD","LU2023250504.SGD","IE0004445015.USD","LU1366192091.USD","LU1868837136.USD","LU1064131342.USD","IE00BJT1NW94.SGD","BK4007","LU0323591593.USD","BK4585","SGXZ51526630.SGD","SG9999015978.USD","LU1057294990.SGD","LU2237443895.HKD","LU0882574055.USD","LU0471298694.HKD","LU1623119135.USD","LU1804176565.USD","IE00B7KXQ091.USD","LU0198837287.USD","LU1868836914.USD","LU2461242641.AUD","LU2361044865.SGD","SGXZ57979304.SGD","LU0094547139.USD","IQV","LU1267930730.SGD","LU2237443978.SGD","LU0708995401.HKD","IE00BJLML261.HKD","LU0114720955.EUR","LU0353189763.USD","LU0385154629.USD","LU1093756168.USD","IE00B1XK9C88.USD","LU0456855351.SGD","SG9999014880.SGD","LU0354030511.USD","BK4533","IE00BFSS8Q28.SGD","IE00B4R5TH58.HKD","LU1551013425.SGD","LU0097036916.USD","LU1061106388.HKD","IE00B775H168.HKD","LU0109394709.USD","ELIL","LU0320765992.SGD","LU2552382132.HKD","LU0158827948.USD","LU0432979614.USD","IE00BWXC8680.SGD","SG9999014914.USD","LU1720051108.HKD","IE00BKPKM429.USD","LU0889565916.HKD","LU0203202063.USD","LU0964807845.USD","LU0256863902.USD","LU1323610961.USD","LU2168564065.EUR","ELIS","LU1814569148.SGD","LU0106261372.USD","LU2462157665.USD","LU2111349929.HKD","IE00BJJMRX11.SGD","LU2168564495.EUR","LU2168563687.JPY","LU2237443549.SGD","LU2063271972.USD","LU1989771016.USD","LU1629891620.HKD","LU0122379950.USD","LU2552382058.USD","SGXZ31699556.SGD","LU2324357040.USD","LU0158827781.USD","LLYZ","LU2471134879.HKD","IE00BFTCPJ56.SGD","IE00BK4W5M84.HKD","SG9999015945.SGD","LU2491050154.USD","SG9999017495.SGD","LU2491049909.HKD","LU2552382215.SGD","IE00B4JS1V06.HKD","LU0289739699.SGD","SG9999001176.SGD","LU0203201768.USD","LU2089984988.USD","LU2750360641.GBP","LU2896262040.SGD","LU2271345857.HKD","LU2089284900.SGD","LU2602419157.SGD","LU2491050071.SGD","LU1127390331.HKD","LU2746668974.SGD","SG9999018865.SGD","BK4581","LU0256863811.USD","LU2471134796.USD","LU0471298777.SGD","LU2089283258.USD","SG9999014906.USD","LLY","LU0882574139.USD","LU2028103732.USD","LU2264538146.SGD","LLII","IE00BJJMRZ35.SGD","LU2456880835.USD","LU2112291526.USD","LU0354030438.USD","LU0820561909.HKD","LU1232071149.USD","BK4534","IE00BN29S564.USD","LU1988902786.USD","LU2236285917.USD","LU2237443465.HKD","LU2468319806.SGD","LU0061475181.USD","IE0009355771.USD","LU0234572021.USD","LU1280957306.USD","LU2237443382.USD","LU2756315318.SGD","SGXZ99366536.SGD","LU0109391861.USD","LU1868837300.USD","LU1548497426.USD","LU0079474960.USD","LU2361045086.USD","LU0006306889.USD","LU2471134523.USD","LU2756315664.SGD","LU0238689110.USD","LU0320765059.SGD","LU2023250330.USD","BK4588","LU2265009873.SGD","IE00B2B36J28.USD","IE00BFSS7M15.SGD","IE0004445239.USD","LU2237443622.USD","LU0787776722.HKD","SG9999014898.SGD","LU2417539215.USD","IE0005OL40V9.USD","LU0316494557.USD","LU2361044949.HKD","IE00B1BXHZ80.USD","LU1868836591.USD","LU1145028129.USD","BK4599","LU0210536198.USD","LU0786609619.USD","LU1917777945.USD","LU1720051017.SGD","LLYX","BK4516","GB00BDT5M118.USD","LU0417517546.SGD","LU0820562030.AUD","IE0002141913.USD","LU2357305700.SGD","SG9999018857.SGD","LU2023251221.USD","LU0672654240.SGD","IE00BJJMRY28.SGD","LU1069344957.HKD","IE00BK4W5L77.USD","IE00BKDWB100.SGD","LU2750360997.AUD","LU2106854487.HKD","LU1983299246.USD","LU0266013472.USD","LU1712237335.SGD","LU1291159041.SGD","LU0823434740.USD","LU1868836757.USD","LU2087625088.SGD","IE0001KFT4U8.USD","SG9999001176.USD","LU2108987350.USD","LU1974910355.USD","LU0353189680.USD","LU0058720904.USD","LU1023059063.AUD","SG9999015986.USD","LU0823434583.USD","LU1035775433.USD","LU0820561818.USD","LU2168564222.USD","LU2360106947.USD","SGXZ81514606.USD","LU1551013342.USD","SG9999013999.USD","LU0943347566.SGD","LU2213496289.HKD","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164910817","title":"异动解读 | 艾昆纬盘中大涨5.19%，因上调年度盈利预期且一季度财报超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1164910817","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1164910817?lang=zh_cn&edition=full","pubTime":"2026-05-06 01:24","pubTimestamp":1778001890,"startTime":"0","endTime":"0","summary":"艾昆纬今日盘中股价大幅上涨5.19%，引起了市场的广泛关注。消息面上，该公司在发布第一季度财报后上调了2026年全年盈利预期，将调整后每股收益预测区间从之前的12.55美元至12.85美元上调至12.65美元至12.95美元，高于分析师平均预期的12.70美元。同时，公司第一季度经调整后每股收益为2.90美元，营收达41.5亿美元，双双超出市场预期，显示出其业务表现强劲。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179551504","title":"艾昆纬高管：未来四至五年专利到期潮将推动制药企业加速管线补充，提升CRO服务需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1179551504","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179551504?lang=zh_cn&edition=full","pubTime":"2026-05-05 21:59","pubTimestamp":1777989551,"startTime":"0","endTime":"0","summary":"艾昆纬高管指出，未来四到五年内即将到来的专利到期事件将促使制药行业加快研发管线补充步伐，从而进一步刺激对合同研究组织服务的需求增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989764664.SGD","LU0130518102.USD","LU1201861249.SGD","LU0477156797.USD","LU0198837287.USD","LU0130103400.USD","BK4585","LU0648001328.SGD","IQV","LU1989764748.USD","LU0130517989.USD","LU1261432733.SGD","LU0528227936.USD","LU0477156953.USD","LU1201861165.SGD","LU0648000940.SGD","BK4121","LU0980610538.SGD","LU1791710582.SGD","BK4588","BK4530","LU1791710400.SGD","LU0882574055.USD","LU0130102774.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142544774","title":"艾昆纬高管称需求环境已企稳 但大型投资方仍对资本部署持审慎态度","url":"https://stock-news.laohu8.com/highlight/detail?id=1142544774","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142544774?lang=zh_cn&edition=full","pubTime":"2026-05-05 21:49","pubTimestamp":1777988940,"startTime":"0","endTime":"0","summary":"艾昆纬高管指出，当前市场需求环境已趋于稳定，然而大型机构投资者在资本配置策略上依然保持更为谨慎的节奏。尽管整体行业呈现复苏迹象，这些主要资金方仍倾向于采取分阶段、精细化的投资决策方式，反映出对市场波动风险的持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","LU1261432733.SGD","LU0130103400.USD","LU0648001328.SGD","LU1791710400.SGD","LU0980610538.SGD","LU0648000940.SGD","IQV","LU1989764748.USD","BK4121","LU0477156953.USD","LU0198837287.USD","LU1989764664.SGD","LU0477156797.USD","LU1201861165.SGD","LU0528227936.USD","BK4585","LU0130102774.USD","LU1201861249.SGD","LU0130518102.USD","LU0882574055.USD","BK4588","BK4530","LU1791710582.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181440449","title":"异动解读 | 财报关键指标不及预期，艾昆纬盘前大跌6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181440449","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1181440449?lang=zh_cn&edition=full","pubTime":"2026-05-05 21:32","pubTimestamp":1777987969,"startTime":"0","endTime":"0","summary":"艾昆纬(IQV)今日盘前股价大跌6.79%，引发了市场的广泛关注。消息面上，公司公布了第一季度财报，虽然调整后每股收益和营收均超过分析师预期，但订单与开票额比率（即簿记对账单比率）为1.04倍，低于分析师的预估平均值，这一关键指标的疲软表现是导致股价下跌的主要原因。公司高管在随后的电话会议中解释称，第一季度簿记对账单比率偏低，主要源于临床实验适应症组合异常，导致转嫁预订量处于非典型的低位水平。分析师指出，这一比率数据很可能掩盖了公司整体稳健的业绩表现。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114463867","title":"艾昆纬高管称一季度簿记对账单比率偏低源于临床实验适应症组合导致的异常低转嫁预订量——电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1114463867","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114463867?lang=zh_cn&edition=full","pubTime":"2026-05-05 21:13","pubTimestamp":1777986795,"startTime":"0","endTime":"0","summary":"艾昆纬高管在电话会议中表示，第一季度簿记对账单比率偏低的主要原因是临床实验适应症组合异常，导致转嫁预订量处于非典型低位水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","IQV","LU1201861249.SGD","BK4588","LU1989764664.SGD","LU0130103400.USD","LU0882574055.USD","LU1201861165.SGD","LU1791710400.SGD","LU0198837287.USD","LU0130518102.USD","LU0528227936.USD","LU1989764748.USD","LU1261432733.SGD","LU0130517989.USD","LU0477156797.USD","LU0648001328.SGD","LU0130102774.USD","LU1791710582.SGD","LU0980610538.SGD","LU0477156953.USD","LU0648000940.SGD","BK4585","BK4530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160129009","title":"OpenAI两大更新！推出药物研发模型挑战谷歌，发布Codex可操作电脑持续性工作","url":"https://stock-news.laohu8.com/highlight/detail?id=1160129009","media":"华尔街见闻","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1160129009?lang=zh_cn&edition=full","pubTime":"2026-04-17 07:06","pubTimestamp":1776380807,"startTime":"0","endTime":"0","summary":"OpenAI正式进军AI辅助药物研发领域，向谷歌等竞争对手发起挑战，并引发相关上市公司股价大幅下挫。OpenAI还宣布对旗下Codex产品进行更新，新版本支持与用户协同操控电脑，兼容更多常用工具与应用，并可记忆用户偏好、学习历史操作习惯。不过，Joy Jiao同时强调，OpenAI目前并不认为AI可以独立提出新的疾病治疗方案。Codex更新：拓展日常工具协作能力OpenAI发布Codex更新。","market":"us","thumbnail":"https://static.tigerbbs.com/760056d3ed9e8c1a595c0d9f2094cc4d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/760056d3ed9e8c1a595c0d9f2094cc4d"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3770180","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"OpenAI两大更新！推出药物研发模型挑战谷歌，发布Codex可操作电脑持续性工作","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1762389672944","symbols":["RXRX","SDGR","CRL","IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512016486","title":"小摩：维持IQVIA Hldgs(IQV.US)评级，由增持调整至增持评级, 目标价由240.00美元调整至232.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512016486","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512016486?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:45","pubTimestamp":1739893533,"startTime":"0","endTime":"0","summary":"小摩：维持IQVIA Hldgs(IQV.US)评级，由增持调整至增持评级, 目标价由240.00美元调整至232.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/18234548240145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511696257","title":"艾昆纬涨2.01% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511696257?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:43","pubTimestamp":1739544189,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时43分，艾昆纬股票出现波动，股价快速拉升2.01%。截至发稿，该股报200.00美元/股，成交量5.9434万股，换手率0.03%，振幅1.22%。艾昆纬股票所在的生命科学行业中，整体涨幅为0.65%。艾昆纬公司简介：艾昆纬控股有限公司是2016年 昆泰，一家全球领先的合同研究组织和 艾美仕，一家领先的医疗数据和分析提供商合并而成的结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224309a24603bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214224309a24603bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0130102774.USD","LU0130518102.USD","LU1791710400.SGD","LU0477156797.USD","BK4585","LU1201861249.SGD","LU1791710582.SGD","LU0130517989.USD","BK4588","LU1989764748.USD","BK4530","LU1261432733.SGD","LU0980610538.SGD","LU1201861165.SGD","BK4121","LU0198837287.USD","LU1989764664.SGD","LU0130103400.USD","LU0648000940.SGD","LU0648001328.SGD","LU0882574055.USD","LU0477156953.USD","IQV","LU0528227936.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iqvia.com","stockEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":0.0352},{"period":"3month","weight":0.4024},{"period":"6month","weight":0.5718},{"period":"1year","weight":0.5091},{"period":"ytd","weight":0.2021}],"compareEarnings":[{"period":"1week","weight":-0.0102},{"period":"1month","weight":-0.0049},{"period":"3month","weight":0.0252},{"period":"6month","weight":0.1684},{"period":"1year","weight":0.1568},{"period":"ytd","weight":0.1227}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"IQVIA Holdings Inc.成立于1982年。IQVIA是一家为生命科学和医疗保健行业提供临床研究服务、商业洞察和医疗保健智能的全球领先供应商。该公司致力于加速创新医疗疗法的开发和商业化，以帮助改善全球范围内的患者预后和人口健康。","yearOnYearQuotes":[{"month":1,"riseRate":0.692308,"avgChangeRate":0.004492},{"month":2,"riseRate":0.461538,"avgChangeRate":0.000669},{"month":3,"riseRate":0.538462,"avgChangeRate":-0.021847},{"month":4,"riseRate":0.307692,"avgChangeRate":0.008636},{"month":5,"riseRate":0.615385,"avgChangeRate":0.020442},{"month":6,"riseRate":0.714286,"avgChangeRate":0.03573},{"month":7,"riseRate":0.857143,"avgChangeRate":0.096714},{"month":8,"riseRate":0.571429,"avgChangeRate":0.010897},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.029804},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.000816},{"month":11,"riseRate":0.692308,"avgChangeRate":0.036781},{"month":12,"riseRate":0.538462,"avgChangeRate":0.01275}],"exchange":"NYSE","name":"艾昆纬","nameEN":"IQVIA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾昆纬(IQV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾昆纬(IQV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾昆纬,IQV,艾昆纬股票,艾昆纬股票老虎,艾昆纬股票老虎国际,艾昆纬行情,艾昆纬股票行情,艾昆纬股价,艾昆纬股市,艾昆纬股票价格,艾昆纬股票交易,艾昆纬股票购买,艾昆纬股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾昆纬(IQV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾昆纬(IQV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}